Nothing Special   »   [go: up one dir, main page]

DK0923942T3 - 5-alfa-reductaseinhiberende præparat til oral indgivelse, fremgangsmåde til fremstilling af samme og anvendelse heraf - Google Patents

5-alfa-reductaseinhiberende præparat til oral indgivelse, fremgangsmåde til fremstilling af samme og anvendelse heraf

Info

Publication number
DK0923942T3
DK0923942T3 DK97901835T DK97901835T DK0923942T3 DK 0923942 T3 DK0923942 T3 DK 0923942T3 DK 97901835 T DK97901835 T DK 97901835T DK 97901835 T DK97901835 T DK 97901835T DK 0923942 T3 DK0923942 T3 DK 0923942T3
Authority
DK
Denmark
Prior art keywords
preparation
alpha
oral administration
reductase inhibitor
same
Prior art date
Application number
DK97901835T
Other languages
English (en)
Inventor
Fusao Usui
Yuko Ohuchi
Akira Kusai
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0923942T3 publication Critical patent/DK0923942T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97901835T 1996-02-05 1997-02-04 5-alfa-reductaseinhiberende præparat til oral indgivelse, fremgangsmåde til fremstilling af samme og anvendelse heraf DK0923942T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1871896 1996-02-05
PCT/JP1997/000273 WO1997027875A1 (fr) 1996-02-05 1997-02-04 PREPARATION INHIBITRICE DE LA 5α-REDUCTASE ADMINISTRABLE PAR VOIE ORALE, PROCEDE DE PRODUCTION ET UTILISATION

Publications (1)

Publication Number Publication Date
DK0923942T3 true DK0923942T3 (da) 2001-12-17

Family

ID=11979447

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97901835T DK0923942T3 (da) 1996-02-05 1997-02-04 5-alfa-reductaseinhiberende præparat til oral indgivelse, fremgangsmåde til fremstilling af samme og anvendelse heraf

Country Status (18)

Country Link
US (1) US20020015732A1 (da)
EP (1) EP0923942B1 (da)
KR (1) KR19990082277A (da)
CN (1) CN1215339A (da)
AT (1) ATE208631T1 (da)
AU (1) AU709146B2 (da)
CZ (1) CZ289856B6 (da)
DE (1) DE69708307T2 (da)
DK (1) DK0923942T3 (da)
ES (1) ES2165017T3 (da)
HK (1) HK1020258A1 (da)
HU (1) HUP9901870A3 (da)
MX (1) MX9806292A (da)
NO (1) NO983580L (da)
NZ (1) NZ326897A (da)
PT (1) PT923942E (da)
RU (1) RU2154467C2 (da)
WO (1) WO1997027875A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998038207A1 (fr) * 1997-02-26 1998-09-03 Sankyo Company, Limited Compositions de traitement ou de prevention du cancer de la prostate
IL134199A0 (en) * 1997-07-29 2001-04-30 Sankyo Co MEDICAMENTS CONTAINING 5α-ANDROST-1-ENE-17β-CARBOXAMIDE DERIVATIVES
CN110643557B (zh) * 2019-04-23 2021-12-31 天津科技大学 一种基因工程菌的构建及其在高效催化5α-雄烯二酮生产中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
ZA851426B (en) * 1984-02-27 1986-10-29 Merck & Co Inc 17 beta-n-monosubstituted carbamoyl-4-aza-5 alpha-androst-1-en-3-ones as 5 alpha reductase inhibitors
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JPH06293793A (ja) * 1993-02-10 1994-10-21 Sankyo Co Ltd ステロイド−１７−アミド類の製造法

Also Published As

Publication number Publication date
MX9806292A (es) 1998-11-30
US20020015732A1 (en) 2002-02-07
DE69708307T2 (de) 2002-08-14
CN1215339A (zh) 1999-04-28
NO983580D0 (no) 1998-08-04
ATE208631T1 (de) 2001-11-15
CZ289856B6 (cs) 2002-04-17
AU1558997A (en) 1997-08-22
AU709146B2 (en) 1999-08-19
DE69708307D1 (de) 2001-12-20
HK1020258A1 (en) 2000-04-07
PT923942E (pt) 2002-03-28
EP0923942A4 (da) 1999-06-23
NO983580L (no) 1998-10-02
WO1997027875A1 (fr) 1997-08-07
EP0923942A1 (en) 1999-06-23
ES2165017T3 (es) 2002-03-01
HUP9901870A2 (hu) 1999-09-28
CZ234298A3 (cs) 1998-11-11
RU2154467C2 (ru) 2000-08-20
NZ326897A (en) 1999-08-30
EP0923942B1 (en) 2001-11-14
KR19990082277A (ko) 1999-11-25
HUP9901870A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
DK1110542T3 (da) Oral metoprololdoseringsform til anvendelse én gang om dagen
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
GB2341801B (en) Formulation
DK0700284T3 (da) Oxybutyninformuleringer med kontrolleret frigivelse
GEP20053474B (en) Glucocorticoid Receptor Modulators
BR0210078A (pt) Composto, uso do mesmo, e, formulação farmacêutica
DK0730444T3 (da) Præparater med opretholdt frigivelse til 24-timers frigivelse af metoprolol.
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
DE69320339D1 (de) Derivate des Dolastatin
DK1053000T3 (da) Midler og fremgangsmåder til beskyttelse, behandling og udbedring af bindevæv
DK0923942T3 (da) 5-alfa-reductaseinhiberende præparat til oral indgivelse, fremgangsmåde til fremstilling af samme og anvendelse heraf
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
YU10599A (sh) Amorfni benzotiofeni, postupak dobijanja istih i njihova farmaceutska formulacija
MX9305998A (es) 6-heterociclic-4-amino-1, 3, 4, 5,-tetrahidrobenz[cd] indoles yprocedimiento para su preparacion.
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
MY126962A (en) A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
ATE219491T1 (de) Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE227122T1 (de) Stabilisierte tablettenformulierung
NO982112L (no) Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor og en kalsiumkanal antagonist, fremgangsmÕte for fremstilling og anvendelse derav i behandling av kardiovaskulµre sykdommer
DK0835656T3 (da) Kombinationspræparat indeholdende tramadol og en calciumkanalantagonist
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE60029979D1 (de) LIPOSOMZUSAMMENSETZUNG VON 6,9-BIS-i(2-AMINOETHYL)-AMINOöBENZOiGöISOQUINOLIN-5,10-DIONE-DIMALEAT